For the quarter ending 2026-03-31, RNA has $292,360K in assets. $58,256K in debts. $267,849K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Prepaid and other current assets | - | 101,598 | 90,181 | 67,416 |
| Marketable securities | - | 1,314,352 | 1,525,678 | 939,237 |
| Cash and cash equivalents | 267,849 | 382,517 | 350,158 | 243,907 |
| Collaboration receivables | 15,000 | - | - | - |
| Prepaid assets | 2,578 | - | - | - |
| Other current assets | 138 | - | - | - |
| Total current assets | 285,565 | 1,798,467 | 1,966,017 | 1,250,560 |
| Restricted cash | 415 | 2,797 | 2,798 | 2,798 |
| Other assets | - | 82,175 | 91,042 | 90,806 |
| Property and equipment, net | 4,337 | 23,333 | 21,504 | 20,535 |
| Right-of-use asset | 2,043 | 51,278 | 52,848 | 4,227 |
| Total assets | 292,360 | 1,958,050 | 2,134,209 | 1,368,926 |
| Accounts payable | 807 | 12,403 | 9,626 | 3,914 |
| Accrued liabilities | 6,983 | - | - | - |
| Accrued expenses and other liabilities | - | 157,466 | 137,163 | 95,236 |
| Accrued compensation | 2,091 | - | - | - |
| Lease liabilities | 2,680 | 3,938 | 3,967 | 3,925 |
| Accrued compensation | - | - | - | 18,449 |
| Deferred revenue, current portion | 9,344 | 21,639 | 19,123 | 13,537 |
| Total current liabilities | 21,905 | 195,446 | 169,879 | 135,061 |
| Lease liabilities, net of current portion | - | 45,313 | 45,999 | 1,210 |
| Deferred revenue, net of current portion | 36,351 | 28,691 | 32,066 | 39,991 |
| Other long-term liabilities | 0 | - | - | - |
| Total liabilities | 58,256 | 269,450 | 247,944 | 176,262 |
| Common stock, 0.001 par value 400,000,000 shares authorized and no shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 16 | 15 | 15 | 12 |
| Additional paid-in capital | - | 3,263,720 | 3,225,078 | 2,357,029 |
| Accumulated other comprehensive income | - | 2,562 | 1,768 | 1,777 |
| Additional paid-in capital | 221,960 | - | - | - |
| Retained earnings | 12,128 | -1,577,697 | -1,340,596 | -1,166,154 |
| Net investment from former parent | 0 | - | - | - |
| Total stockholders' equity / former parent's deficit | 234,104 | 1,688,600 | 1,886,265 | 1,192,664 |
| Total liabilities and stockholders' equity / former parent's deficit | 292,360 | 1,958,050 | 2,134,209 | 1,368,926 |
Avidity Biosciences, Inc. (RNA)
Avidity Biosciences, Inc. (RNA)